We are live on
!
Find out more
ImmunityBio
IBRX
IBRX
386 hedge funds and large institutions have $1.36B invested in ImmunityBio in 2026 Q1 according to their latest regulatory filings, with 145 funds opening new positions, 136 increasing their positions, 60 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
383% more first-time investments, than exits
New positions opened: 145 | Existing positions closed: 30
302% more capital invested
Capital invested by funds: $339M → $1.36B (+$1.02B)
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
127% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 60
43% more call options, than puts
Call options by funds: $165M | Put options by funds: $115M
40% more funds holding
Funds holding: 276 → 386 (+110)
0.18% more ownership
Funds ownership: 17.2% → 17.38% (+0.18%)
Holders
386
Holders Change
+110
Holders Change %
+39.86%
% of All Funds
4.75%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
145
Increased
136
Reduced
60
Closed
30
Calls
$165M
Puts
$115M
Net Calls
+$49.7M
Net Calls Change
+$52.8M
Top Buyers
| 1 |
D.E. Shaw & Co
New York
|
+$86.1M |
| 2 |
HF
HRT Financial
New York
|
+$26.9M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$20M |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$10.2M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$9.62M |
Top Sellers
| 1 |
Jane Street
New York
|
-$92.6M |
| 2 |
AC
AlphaCore Capital
La Jolla,
California
|
-$20.4M |
| 3 |
Goldman Sachs
New York
|
-$20M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.9M |
| 5 |
Morgan Stanley
New York
|
-$7.44M |
